Top stock gainer No.1: Lacrosse Footwear Inc. (BOOT) surged 81.06%, or $8.90, to finish at $19.88 Friday, on volume of 2.56 million shares, far above the daily average of 4,852 shares. Today’s surge followed the news that ABC-MART will acquire the company for about $20 per share in cash and totally for $138 million. BOOT stock price is above the 50-day moving average of $11.73 and the 200-day moving average of $12.53. Lacrosse Footwear has a market cap of $129.41 million.
Top stock gainer No.2: Sunshine Heart Inc. (SSH) rose sharply by 65.78%, or $1.98 to close at $4.99 Friday, on volume of 108,929 shares, well higher than the daily average of 2,544 shares. On Tursday, the medical device company received approval by Health Canada to use its next generation C-Pulse® Heart Assist System driver in ongoing clinical studies at Royal Victoria Hospital. SSH stock price is below the 50-day moving average of $6.34. Sunshine Heart has a market cap of $18.90 million.
Top stock gainer No.3: Asure Software, Inc. (ASUR) shot up 33.26%, or $1.62, to close at $6.49 today, on volume of 108,929 shares, far above the daily average of 2,544 shares. Asure Software on Tursday announced the acquisition of the Massachusetts-based PeopleCube Inc for $9.8 million in cash. ASUR stock price is above the 50-day moving average of $4.60 and the 200-day moving average of $4.06. Asure Software has a market cap of $32.34 million.
Top stock gainer No.4: Central Federal Corp. (CFBK) was up 26.62%, or $0.37, to $1.76, on volume of 6,165 versus the daily average of 1,087 shares. CFBK stock price plunged 18.24% Turday. CFBK stock price is below the 50-day moving average of $1.89 and the 200-day moving average of $3.42. Central Federal has a market cap of $1.45 million.
Top stock gainer No.5: Supernus Pharmaceuticals, Inc. (SUPN) jumped 24.74%, or $2.39, to end at $12.05, on volume of 726,009 shares versus the daily average of 252,351 shares. Supernus Pharmaceuticals saw the big gain after the company announced it had received tentative approval from the U.S. Food and Drug Administration. Central Federal has a market cap of $293.81 million.